NRAS G12D
Oncology·MeSH: Ovarian Neoplasms
0 drugs in development·0 companies·4 clinical trials
Deep-dive into NRAS G12D
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free AnalysisFull trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis